TY - JOUR
T1 - Redundancy renders the glycoprotein 96 receptor scavenger receptor A dispensable for cross priming in vivo
AU - Tewalt, Eric F.
AU - Maynard, Jason C.
AU - Walters, Julie Jo
AU - Schell, Amanda M.
AU - Berwin, Brent L.
AU - Nicchitta, Christopher V.
AU - Norbury, Christopher C.
PY - 2008/12
Y1 - 2008/12
N2 - CD8+ T cells (TCD8+) differentiate into effector cells following recognition of specific peptide-major histocompatibility complex (MHC) class I complexes (pMHC-I) on the surface of professional APCs (pAPCs), such as dendritic cells. Antigenic pMHC-I can be generated from two spatially distinct sources. The direct presentation pathway involves generation of peptide from protein substrate synthesized within the cell that is presenting the pMHC-I. Alternatively, the cross presentation pathway involves presentation of antigen that is not synthesized within the presenting cell, but is derived from exogenous proteins synthesized within other donor cells. The mechanisms by which cross presentation of exogenous antigens occur in vivo remain controversial. The C-type lectin scavenger receptor A (SR-A) has been implicated in a number of potential cross presentation pathways, including the presentation of peptide bound to heat shock proteins, such as glycoprotein 96 (gp96), and the transfer of pMHC-I from a donor cell to the pAPC. We demonstrate here that initiation of TCD8+ responses is normal in mice lacking SR-A, and that the redundancy of ligand binding exhibited by the SR family is likely to be an important mechanism that ensures cross presentation in vivo. These observations emphasize the requirement to target multiple receptors and antigen-processing pathways during the rational design of vaccines aimed at eliciting protective TCD8+.
AB - CD8+ T cells (TCD8+) differentiate into effector cells following recognition of specific peptide-major histocompatibility complex (MHC) class I complexes (pMHC-I) on the surface of professional APCs (pAPCs), such as dendritic cells. Antigenic pMHC-I can be generated from two spatially distinct sources. The direct presentation pathway involves generation of peptide from protein substrate synthesized within the cell that is presenting the pMHC-I. Alternatively, the cross presentation pathway involves presentation of antigen that is not synthesized within the presenting cell, but is derived from exogenous proteins synthesized within other donor cells. The mechanisms by which cross presentation of exogenous antigens occur in vivo remain controversial. The C-type lectin scavenger receptor A (SR-A) has been implicated in a number of potential cross presentation pathways, including the presentation of peptide bound to heat shock proteins, such as glycoprotein 96 (gp96), and the transfer of pMHC-I from a donor cell to the pAPC. We demonstrate here that initiation of TCD8+ responses is normal in mice lacking SR-A, and that the redundancy of ligand binding exhibited by the SR family is likely to be an important mechanism that ensures cross presentation in vivo. These observations emphasize the requirement to target multiple receptors and antigen-processing pathways during the rational design of vaccines aimed at eliciting protective TCD8+.
UR - http://www.scopus.com/inward/record.url?scp=55449088718&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=55449088718&partnerID=8YFLogxK
U2 - 10.1111/j.1365-2567.2008.02861.x
DO - 10.1111/j.1365-2567.2008.02861.x
M3 - Article
C2 - 18489571
AN - SCOPUS:55449088718
SN - 0019-2805
VL - 125
SP - 480
EP - 491
JO - Immunology
JF - Immunology
IS - 4
ER -